ENT (Ear, Nose and Throat)

Prescription drugs and medicines for conditions relating to ENT (ears, nose, and throat). Otolaryngology is the study of diseases involving the ears and the larynx (organ that helps produce vocal sounds and serves as an air passageway, located in the neck/throat). Studies in this area include: allergy, ear infections, pneumonia, rhinitis, sinus infections, strep throat, and others.

The list of FDA approved drugs for ENT (Ear, Nose and Throat) appears below. Click any link to view the full drug information.

Number approved drugs in "ENT (Ear, Nose and Throat)": 25

FDA Approved ENT (Ear, Nose and Throat) Listings:

The rules of principle for evaluating MediLexicon's FDA ent (ear, nose and throat) listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.

MediLexicon's FDA Approved Drugs Listings include:

New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.

MediLexicon's FDA Approved Drugs Listings do NOT include:

Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.


ENT (Ear, Nose and Throat) Drug Information

The ent (ear, nose and throat) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top